Selected article for: "day post inoculation and post inoculation"

Author: van Doremalen, Neeltje; Schäfer, Alexandra; Menachery, Vineet D.; Letko, Michael; Bushmaker, Trenton; Fischer, Robert J.; Figueroa, Dania M.; Hanley, Patrick W.; Saturday, Greg; Baric, Ralph S.; Munster, Vincent J.
Title: SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus)
  • Cord-id: 6bbvolcc
  • Document date: 2018_12_19
  • ID: 6bbvolcc
    Snippet: Severe acute respiratory syndrome (SARS)-like WIV1-coronavirus (CoV) was first isolated from Rhinolophus sinicus bats and can use the human angiotensin converting enzyme 2 (ACE2) receptor. In the current study, we investigate the ability of WIV1-CoV to infect Rousettus aegyptiacus bats. No clinical signs were observed throughout the experiment. Furthermore, only four oropharyngeal swabs and two respiratory tissues, isolated on day 3 post inoculation, were found positive for viral RNA. Two out of
    Document: Severe acute respiratory syndrome (SARS)-like WIV1-coronavirus (CoV) was first isolated from Rhinolophus sinicus bats and can use the human angiotensin converting enzyme 2 (ACE2) receptor. In the current study, we investigate the ability of WIV1-CoV to infect Rousettus aegyptiacus bats. No clinical signs were observed throughout the experiment. Furthermore, only four oropharyngeal swabs and two respiratory tissues, isolated on day 3 post inoculation, were found positive for viral RNA. Two out of twelve bats showed a modest increase in coronavirus specific antibodies post challenge. In conclusion, WIV1-CoV was unable to cause a robust infection in Rousettus aegyptiacus bats.

    Search related documents:
    Co phrase search for related documents
    • abnormal value and lymph node: 1
    • acute sars cov respiratory syndrome coronavirus and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65
    • acute sars cov respiratory syndrome coronavirus and adaptive immune response result: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and adrenal gland: 1, 2, 3, 4, 5, 6, 7, 8
    • acute sars cov respiratory syndrome coronavirus and liver change: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and liver tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute sars cov respiratory syndrome coronavirus and liver tissue spleen: 1
    • acute sars cov respiratory syndrome coronavirus and low level virus: 1
    • acute sars cov respiratory syndrome coronavirus and lung weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute sars cov respiratory syndrome coronavirus and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and lysis buffer: 1, 2, 3
    • adaptive immune response and adrenal gland: 1
    • adaptive immune response and lymph node: 1, 2, 3, 4, 5, 6
    • adrenal gland and liver tissue: 1
    • adrenal gland and lymph node: 1, 2, 3, 4, 5, 6
    • liver tissue and lymph node: 1, 2, 3, 4
    • liver tissue and lysis buffer: 1
    • liver tissue spleen and lymph node: 1